[PETGAS] QoQ Cumulative Quarter Result on 30-Jun-2017 [#2]

Announcement Date
15-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- 91.82%
YoY- 4.42%
View:
Show?
Cumulative Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 1,350,766 4,809,623 3,505,868 2,342,660 1,169,148 4,561,280 3,407,337 -46.06%
PBT 636,985 2,252,713 1,646,819 1,114,178 577,047 2,106,769 1,622,777 -46.42%
Tax -131,633 -435,780 -340,328 -225,087 -113,886 -370,468 -349,947 -47.92%
NP 505,352 1,816,933 1,306,491 889,091 463,161 1,736,301 1,272,830 -46.01%
-
NP to SH 483,224 1,792,682 1,305,987 888,560 463,235 1,739,052 1,273,632 -47.62%
-
Tax Rate 20.67% 19.34% 20.67% 20.20% 19.74% 17.58% 21.56% -
Total Cost 845,414 2,992,690 2,199,377 1,453,569 705,987 2,824,979 2,134,507 -46.09%
-
Net Worth 12,650,429 12,515,084 12,319,783 12,205,610 12,060,965 11,966,777 11,843,502 4.49%
Dividend
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Div 316,597 1,305,963 989,366 613,406 296,809 1,226,813 890,429 -49.84%
Div Payout % 65.52% 72.85% 75.76% 69.03% 64.07% 70.54% 69.91% -
Equity
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Net Worth 12,650,429 12,515,084 12,319,783 12,205,610 12,060,965 11,966,777 11,843,502 4.49%
NOSH 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 0.00%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 37.41% 37.78% 37.27% 37.95% 39.62% 38.07% 37.36% -
ROE 3.82% 14.32% 10.60% 7.28% 3.84% 14.53% 10.75% -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 68.26 243.07 177.18 118.39 59.09 230.52 172.20 -46.06%
EPS 24.42 90.60 66.00 44.91 23.41 87.89 64.37 -47.62%
DPS 16.00 66.00 50.00 31.00 15.00 62.00 45.00 -49.84%
NAPS 6.3932 6.3248 6.2261 6.1684 6.0953 6.0477 5.9854 4.49%
Adjusted Per Share Value based on latest NOSH - 1,978,732
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 68.26 243.07 177.18 118.39 59.09 230.52 172.20 -46.06%
EPS 24.42 90.60 66.00 44.91 23.41 87.89 64.37 -47.62%
DPS 16.00 66.00 50.00 31.00 15.00 62.00 45.00 -49.84%
NAPS 6.3932 6.3248 6.2261 6.1684 6.0953 6.0477 5.9854 4.49%
Price Multiplier on Financial Quarter End Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 -
Price 17.84 17.48 17.90 18.54 19.76 21.30 21.84 -
P/RPS 26.13 7.19 10.10 15.66 33.44 9.24 12.68 62.00%
P/EPS 73.05 19.29 27.12 41.29 84.41 24.24 33.93 66.81%
EY 1.37 5.18 3.69 2.42 1.18 4.13 2.95 -40.05%
DY 0.90 3.78 2.79 1.67 0.76 2.91 2.06 -42.45%
P/NAPS 2.79 2.76 2.87 3.01 3.24 3.52 3.65 -16.41%
Price Multiplier on Announcement Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 17/05/18 26/02/18 10/11/17 15/08/17 15/05/17 23/02/17 02/11/16 -
Price 17.84 17.66 17.80 18.82 18.58 20.58 22.08 -
P/RPS 26.13 7.27 10.05 15.90 31.45 8.93 12.82 60.82%
P/EPS 73.05 19.49 26.97 41.91 79.37 23.42 34.30 65.60%
EY 1.37 5.13 3.71 2.39 1.26 4.27 2.92 -39.64%
DY 0.90 3.74 2.81 1.65 0.81 3.01 2.04 -42.07%
P/NAPS 2.79 2.79 2.86 3.05 3.05 3.40 3.69 -17.01%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment